Skip to content
DataLookout
Menu

NCT07901114

A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers

StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

AUCt of AJU-C719
Timeframe: Pre-dose(0 hours) ~ 72 hours
Cmax of AJU-C719
Timeframe: Pre-dose(0 hours) ~ 72 hours

Secondary (4)

AUCinf of AJU-C719
Tmax of AJU-C719
t1/2 of AJU-C719
AUCt/AUCinf of AJU-C719

Arms and interventions

Sequence AExperimental

Period 1: Reference Drug, Single dose / Period 2: Test Drug, Single dose

Sequence BExperimental

Period 1: Test Drug, Single dose / Period 2: Reference Drug, Single dose

Drugs: Test Drug, Reference Drug

Sites

1 site in 1 country

  • Bumin Hospital (Seoul)Seoul, Seoul, South Korea